Effects of lysostaphin and its two active components on stable wall-defective forms of Staphylococcus aureus.
D000606:Amino Sugars / Q000032:analysis; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D002462:Cell Membrane / Q000032:analysis; D002473:Cell Wall; D003470:Culture Media; D006026:Glycoside Hydrolases / Q000494:pharmacology; D006595:Hexosamines / Q000032:analysis; D006601:Hexoses / Q000032:analysis; D008248:Lysostaphin / Q000494:pharmacology; D008712:Methicillin / Q000494:pharmacology; D009154:Mutation; D010403:Penicillin Resistance; D010447:Peptide Hydrolases / Q000494:pharmacology; D013210:Staphylococcus / Q000032:analysis / Q000187:drug effects*